HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer.

Abstract
The copper transporters <italic>CTR1</italic>, <italic>CTR2</italic>, <italic>ATP7A</italic>, and <italic>ATP7B</italic> regulate intracellular concentration of platinum by mediating its uptake and efflux in cells. We sought to explore the effect of genetic polymorphisms in <italic>CTR1</italic>, <italic>CTR2</italic>, <italic>ATP7A</italic>, and <italic>ATP7B</italic> on platinum resistance in patients suffering from epithelial ovarian cancer (EOC). A total of 152 Chinese EOC patients were enrolled in this study, all of whom underwent adjuvant chemotherapy using platinum and taxane after maximal debulking surgery. In total, 11 single-nucleotide polymorphisms (SNPs) in <italic>CTR1, CTR2, ATP7A</italic>, and <italic>ATP7B</italic> were genotyped in these patients. The <italic>CTR1</italic> rs10981694 polymorphism was observed to be associated with carboplatin resistance, while patients with the rs10981694 G allele showed a significantly higher rate of carboplatin resistance (OR = 4.00, 95% CI 1.309 - 12.23, p < 0.01). In addition, we found that <italic>ATP7A</italic> rs2227291 was associated with cisplatin resistance and that carriers of the C allele were more sensitive to cisplatin (OR = 0.40, 95% CI: 0.17 - 0.94, p = 0.03). Our findings suggest that the <italic>CTR1</italic> and <italic>ATP7A</italic> genetic polymorphisms could affect platinum resistance. The <italic>CTR1</italic> and <italic>ATP7A</italic> genes might be considered a predictive marker for carboplatin and cisplatin resistance, respectively.
.
AuthorsTailin Li, Jingbo Peng, Feiyue Zeng, Keqiang Zhang, Jinyang Liu, Xi Li, Qianying Ouyang, Guo Wang, Liansheng Wang, Zhaoqian Liu, Yingzi Liu
JournalInternational journal of clinical pharmacology and therapeutics (Int J Clin Pharmacol Ther) Vol. 55 Issue 10 Pg. 774-780 (Oct 2017) ISSN: 0946-1965 [Print] Germany
PMID28737129 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cation Transport Proteins
  • Copper Transporter 1
  • Organoplatinum Compounds
  • SLC31 Proteins
  • SLC31A1 protein, human
  • SLC31A2 protein, human
  • ATP7A protein, human
  • ATP7B protein, human
  • Copper-Transporting ATPases
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Ovarian Epithelial
  • Cation Transport Proteins (genetics)
  • Copper Transporter 1
  • Copper-Transporting ATPases (genetics)
  • Drug Resistance, Neoplasm (genetics)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Glandular and Epithelial (drug therapy, genetics)
  • Organoplatinum Compounds (therapeutic use)
  • Ovarian Neoplasms (drug therapy, genetics)
  • Polymorphism, Single Nucleotide (genetics)
  • SLC31 Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: